Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln (Ketotifen)

Ketotifen blocks histamine H1 receptors on ocular tissues and stabilises mast cells, preventing the release of histamine and other inflammatory mediators. This dual action reduces vascular permeability and sensory nerve activation, thereby decreasing redness, swelling and itching in the conjunctiva.

The dosing regimen for Ketotifen Stulln is determined by the prescribing healthcare professional. Typically, a few drops are instilled in the affected eye(s) as directed, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for ketotifen in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Physicians should evaluate each case individually and discuss risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketotifen combines H1‑receptor antagonism with mast‑cell stabilisation, offering both immediate symptom relief and longer‑term control. Compared with agents such as olopatadine, which primarily block histamine, ketotifen may provide additional anti‑inflammatory benefits, though individual response varies and choice depends on clinical judgement.

Store the eye‑drop bottle at room temperature, away from direct sunlight and moisture. Keep it in the original packaging until use, and discard any remaining solution after the recommended period after opening, typically indicated on the label.

The patient should wash hands, tilt the head back, and gently pull down the lower eyelid to create a small pocket. One or more drops, as prescribed, are placed into the conjunctival sac. The eye should be closed gently for a few seconds to allow distribution.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, and sudden significant loss of vision. If any of these occur, immediate medical attention is required and the medication should be discontinued.

Patients with a known hypersensitivity to ketotifen or any component of the formulation should avoid using the product. Caution is also advised for individuals with uncontrolled glaucoma, active eye infections, or those wearing contact lenses without proper removal before instillation.